866-997-4948(US-Canada Toll Free)

Meningitis Preventive Vaccines - Pipeline Analysis and Market Forecasts to 2017

Published By :

GlobalData

Published Date : Oct 2010

Category :

Therapeutic Area

No. of Pages : 45 Pages


GlobalData, the industry analysis specialist, has released its new report, Meningitis Preventive Vaccines Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global Meningitis Preventive Vaccines market. The report identifies the key trends shaping and driving the global Meningitis Preventive Vaccines market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Meningitis Preventive Vaccines sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

GlobalData has estimated the global Meningitis Preventive Vaccines market to be valued at $1.8 billion in 2009. It is expected to increase to $4.5 billion with a Compound Annual Growth Rate (CAGR) of (12%)by 2017. The market structure is projected to change in the near future following the entrance of new blockbuster products till 2017. Menveo Iis expected to come in the market by 2011 and Novartis menB vaccine by 2014 in US. There is a low unmet need in the current Meningitis Preventive Vaccines market in terms of both safety and efficacy profile

Scope

The report provides information on the key drivers and challenges of the Alzheimers disease market. Its scope includes: 

  • Annualized global Meningitis Preventive Vaccines market revenues data from 2001 to 2009, forecast for eight years to 2017. 
  • Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major vaccine classes such as of conjugate vaccine, recombinant vaccine and antigen vaccine.
  • Analysis of the current and future competition in the global Meningitis Preventive Vaccines market. Key market players covered are Sanofi Pasteur, Merck & Co., Novartis, GSK. 
  • Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. 
  • Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Meningitis Preventive Vaccines market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to:

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. 
  • Develop business strategies by understanding the trends shaping and driving the global Meningitis Preventive Vaccines market. 
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Meningitis Preventive Vaccines market in future. 
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. 
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. 
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. 
  • Whats the next big thing in the global Meningitis Preventive Vaccines market landscape? Identify, understand and capitalize.
Table Of Content

1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 5

2 Meningitis: Introduction 6
2.1 GlobalData Pipeline Report Guide 7

3 Meningitis: Market Characterization 8
3.1 Meningitis Market Size 8
3.2 Meningitis Preventive Market Forecast and CAGR 9
3.3 Drivers and Barriers for the Meningitis Market 10
3.3.1 Drivers for Meningitis Market 10
3.3.2 Barriers for Meningitis Preventive Market 11
3.4 Opportunity and Unmet Need 11
3.5 Key Takeaway 12

4 Meningitis Market: Competitive Assessment 13
4.1 Overview 13
4.2 Strategic Competitor Assessment 13
4.3 Product Profiles for the Major Marketed Products in the Meningitis Preventive Market 14
4.3.1 Menactra 14
4.3.2 ActHIB 15
4.3.3 Neisvac C- 15
4.4 Major Marketed Products Comparison in Meningitis Preventive Market 17
4.5 Key Takeaway 17

5 Meningitis Market: Pipeline Assessment 18
5.1 Technology Trends Analytical Framework 18
5.1.1 Overview 18
5.1.2 Strategic Pipeline Assessment 18
5.2 Meningitis Promising Vaccines/Drugs Under Clinical Development 20
5.3 Molecule Profile for Promising Vaccines/Drugs Under Clinical Development 21
5.3.1 Menveo 21
5.3.2 Meningitis B Vaccine (MenB Vaccine) 21
5.4 Meningitis Market Clinical Pipeline by Vaccine Class 22
5.5 Meningitis Pipeline Pipeline by Clinical Phases of Development 23
5.5.1 Meningitis Phase III Clinical Pipeline 23
5.5.2 Meningitis Phase I Clinical Pipeline 25
5.5.3 Meningitis Discovery and Preclinical Pipeline 25
5.6 Key Takeaway 25

6 Meningitis Preventive Market: Implications for the Future Market Competition 26

7 Global Meningitis Preventive Market: Future Players in Meningitis Market 27
7.1 Introduction 27
7.2 Novartis 27
7.2.1 Company Overview 27
7.2.2 Business Description 28
7.2.3 Novartis - Infectious Diseases Pipeline 29
7.2.4 Novartis - Meningitis Vaccines Pipeline 29
7.3 GlaxoSmithKline 30
7.3.1 Company Overview 30
7.3.2 Business Description 30
7.3.3 GlaxoSmithKline - Infectious Diseases Pipeline 31
7.3.4 GlaxoSmithKline - Meningitis Pipeline 32
7.4 Sanofi-aventis 32
7.4.1 Company Overview 32
7.4.2 Business Description 32
7.4.3 Sanofi-aventis Infectious Diseases Pipeline 33
7.4.4 Sanofi-aventis - Meningitis Pipeline 33
7.5 Merck & Co., Inc. 34
7.5.1 Company Overview 34
7.5.2 Business Description 34
7.5.3 Merck - Infectious Diseases Pipeline 35
7.5.4 Merck - Meningitis Pipeline 36
7.6 Serum Institute of India Limited (SIIL) 36
7.6.1 Company Overview 36
7.6.2 Serum Institute Meningitis Pipeline 37
7.7 Pfizer Inc. 37
7.7.1 Company Overview 37
7.7.2 Business Description 37

8 Global Meningitis Market: Appendix 40
8.1 Market Definitions 40
8.2 Abbreviations 40
8.3 Research Methodology 41
8.3.1 Coverage 41
8.3.2 Secondary Research 41
8.3.3 Forecasting 41
8.3.4 Primary Research 44
8.3.5 Expert Panel Validation 44
8.4 Contact Us 44
8.5 Disclaimer 44
8.6 Sources 45

List of Table


Table 1: Meningitis Preventive Vaccines, Global, Revenue ($m), 20012009 8
Table 2: Meningitis Preventive Vaccines, Global, Market Forecast ($m), 2009-2017 9
Table 3: Major Marketed Products Comparison in Meningitis Preventive Market, 2010 17
Table 4: Meningitis Most Promising Vaccines Under Clinical Development, 2010 20
Table 5: Meningitis Preventive Vaccines Phase III Clinical Pipeline, 2010 23
Table 6: Meningitis Preventive vaccines Phase II Clinical Pipeline, 2010 24
Table 7: Meningitis Preventive Vaccines Phase I Clinical Pipeline, 2010 25
Table 8: Meningitis Preventive vaccines Discovery and Preclinical Pipeline, 2010 25
Table 9: Novartis - Infectious Diseases Pipeline, 2010 29
Table 10: Novartis - Meningitis Pipeline, 2010 29
Table 11: GlaxoSmithKline - Infectious Diseases Pipeline, 2010 31
Table 12: GlaxoSmithKline - Meningitis Pipeline, 2010 32
Table 13: Sanofi-aventis - Infectious Diseases Pipeline, 2010 33
Table 14: Sanofi-aventis - Meningitis Pipeline, 2010 33
Table 15: Merck - Infectious Diseases Pipeline, 2010 35
Table 16: Merck - Meningitis Pipeline, 2010 36
Table 17: Serum Institute Meningitis Pipeline, 2010 37
Table 18: Pfizer - Meningitis Pipeline, 2010 39

List of Chart


Figure 1: Meningitis Preventive Vaccines, Global, Revenue ($m), 20012009 8
Figure 2: Meningitis Preventive Vaccines, Global, Market Forecast ($m), 2009-2017 9
Figure 3: Opportunity and Unmet Need in the Meningitis Preventive Vaccines Market, 2010 12
Figure 4: Strategic Competitor Assessment of the Meningitis Preventive Market, 2010 13
Figure 5: Technology Trends Analytic Framework of the Meningitis Preventive Vaccines Pipeline, 2010 18
Figure 6: Technology Trends Analytic Framework Description - Meningitis Market, 2010 19
Figure 7: Meningitis Preventive Market Clinical Pipeline by Type of Vaccine, 2010 22
Figure 8: Meningitis Preventive Pipeline by Phase of Clinical Development, 2010 23
Figure 9: Global Meningitis Preventive Market : Implications for Future Market Competition in the Meningitis Market, 2010 26
Figure 10: Meningitis Market Clinical Pipeline by Company, 2010 27
Figure 11: GlobalData Market Forecasting Model 43

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *